Volume 29, Number 11—November 2023
Research
Simulation Study of Surveillance Strategies for Faster Detection of Novel SARS-CoV-2 Variants
Table 3
Community testing cohort size (% destination country population) |
Time to detection (days since emergence of index case), summaries from 1,000 simulations |
||||
5th percentile |
25th percentile |
Median |
75th percentile |
95th percentile |
|
20,000 (0.04) | 145 | 165 | 175 | 183 | 191 |
30,000 (0.05) | 144 | 161 | 170 | 178 | 187 |
40,000 (0.07) | 140 | 158 | 168 | 176 | 185 |
50,000 (0.09) | 138.5 | 156 | 166 | 175 | 184 |
60,000 (0.11) | 137 | 155.5 | 165 | 172 | 182 |
70,000 (0.13) | 137 | 154 | 163 | 171 | 181 |
80,000 (0.14) | 136 | 153 | 162 | 170 | 179 |
90,000 (0.16) | 133 | 151 | 161 | 169 | 177 |
100,000 (0.18) | 133.5 | 150.5 | 160 | 168 | 178 |
110,000 (0.20) | 130 | 150 | 159 | 167 | 176 |
120,000 (0.21) | 130 | 148 | 158 | 166.5 | 176 |
130,000 (0.23) | 130.5 | 149 | 158 | 165 | 174 |
140,000 (0.25) | 129 | 148 | 157 | 164 | 173 |
150,000 (0.27) | 129 | 146 | 156 | 163 | 172 |
160,000 (0.29) | 127.5 | 146 | 155.5 | 163 | 172 |
170,000 (0.30) | 127 | 146 | 155 | 164 | 173 |
180.000 (0.32) | 126 | 145 | 154 | 162 | 171 |
190,000 (0.34) | 128 | 145 | 154 | 162 | 173 |
200,000 (0.36) | 127 | 144.5 | 154 | 162 | 171 |
1These senior authors contributed equally to this article.
Page created: September 29, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.